Požymis
Can't control feelings
Klinikinis pavadinimas: Emotional lability
Unstable emotional experiences and frequent mood changes; emotions that are easily aroused, intense, and/or disproportionate to events and circumstances.
Santrauka
- Taip pat vadinama
- Emotional instability, Mood lability
- Kūno sistema
- Abnormality of the nervous system
Read the genes linked to Can't control feelings, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test168 genų susiję su Can't control feelings
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Can't control feelings. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| DEAF1DEAF1 transcription factor | Visada | 3 ligose |
| LEPRleptin receptor | Visada | 2 ligose |
| LRRC7leucine rich repeat containing 7 | Visada | 1 ligoje |
| PDCD6IPprogrammed cell death 6 interacting protein | Visada | 1 ligoje |
| RRP12ribosomal RNA processing 12 homolog | Visada | 1 ligoje |
| CASRcalcium sensing receptor | Labai dažnai (80–99%) | 1 ligoje |
| CLTRNcollectrin, amino acid transport regulator | Labai dažnai (80–99%) | 1 ligoje |
| DDCdopa decarboxylase | Labai dažnai (80–99%) | 1 ligoje |
| GNA11G protein subunit alpha 11 | Labai dažnai (80–99%) | 1 ligoje |
| HDAC8histone deacetylase 8 | Labai dažnai (80–99%) | 1 ligoje |
| LAS1LLAS1 like ribosome biogenesis factor | Labai dažnai (80–99%) | 2 ligose |
| PRNPprion protein (Kanno blood group) | Labai dažnai (80–99%) | 4 ligose |
| SLC6A19solute carrier family 6 member 19 | Labai dažnai (80–99%) | 2 ligose |
| ANGangiogenin | Dažnai (30–79%) | 1 ligoje |
| ANXA11annexin A11 | Dažnai (30–79%) | 1 ligoje |
| ARMC5armadillo repeat containing 5 | Dažnai (30–79%) | 1 ligoje |
| ARSAarylsulfatase A | Dažnai (30–79%) | 4 ligose |
| ATRXATRX chromatin remodeler | Dažnai (30–79%) | 1 ligoje |
| ATXN2ataxin 2 | Dažnai (30–79%) | 1 ligoje |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Dažnai (30–79%) | 1 ligoje |
| CCNFcyclin F | Dažnai (30–79%) | 1 ligoje |
| CDH23cadherin related 23 | Dažnai (30–79%) | 1 ligoje |
| CFAP410cilia and flagella associated protein 410 | Dažnai (30–79%) | 1 ligoje |
| CHCHD10coiled-coil-helix-coiled-coil-helix domain containing 10 | Dažnai (30–79%) | 1 ligoje |
| CHMP2Bcharged multivesicular body protein 2B | Dažnai (30–79%) | 1 ligoje |
| CREBBPCREB binding lysine acetyltransferase | Dažnai (30–79%) | 2 ligose |
| DAOD-amino acid oxidase | Dažnai (30–79%) | 1 ligoje |
| DCTN1dynactin subunit 1 | Dažnai (30–79%) | 1 ligoje |
| EP300EP300 lysine acetyltransferase | Dažnai (30–79%) | 1 ligoje |
| EPM2AEPM2A glucan phosphatase, laforin | Dažnai (30–79%) | 1 ligoje |
| ERBB4erb-b2 receptor tyrosine kinase 4 | Dažnai (30–79%) | 1 ligoje |
| FAM177A1family with sequence similarity 177 member A1 | Dažnai (30–79%) | 1 ligoje |
| FIG4FIG4 phosphoinositide 5-phosphatase | Dažnai (30–79%) | 1 ligoje |
| FMO3flavin containing dimethylaniline monoxygenase 3 | Dažnai (30–79%) | 1 ligoje |
| FTLferritin light chain | Dažnai (30–79%) | 2 ligose |
| FUSFUS RNA binding protein | Dažnai (30–79%) | 1 ligoje |
| GLE1GLE1 RNA export mediator | Dažnai (30–79%) | 1 ligoje |
| GLT8D1glycosyltransferase 8 domain containing 1 | Dažnai (30–79%) | 1 ligoje |
| GNASGNAS complex locus | Dažnai (30–79%) | 2 ligose |
| HNRNPA1heterogeneous nuclear ribonucleoprotein A1 | Dažnai (30–79%) | 1 ligoje |
Rodyti dar 128 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| KDM1Alysine demethylase 1A | Dažnai (30–79%) | 1 ligoje |
| LRP12LDL receptor related protein 12 | Dažnai (30–79%) | 1 ligoje |
| MATR3matrin 3 | Dažnai (30–79%) | 1 ligoje |
| MTPAPmitochondrial poly(A) polymerase | Dažnai (30–79%) | 2 ligose |
| NEFHneurofilament heavy chain | Dažnai (30–79%) | 1 ligoje |
| NEK1NIMA related kinase 1 | Dažnai (30–79%) | 1 ligoje |
| NHLRC1NHL repeat containing E3 ubiquitin protein ligase 1 | Dažnai (30–79%) | 1 ligoje |
| NOTCH3notch receptor 3 | Dažnai (30–79%) | 1 ligoje |
| NR3C1nuclear receptor subfamily 3 group C member 1 | Dažnai (30–79%) | 1 ligoje |
| NTRK1neurotrophic receptor tyrosine kinase 1 | Dažnai (30–79%) | 1 ligoje |
| OPTNoptineurin | Dažnai (30–79%) | 1 ligoje |
| PANK2pantothenate kinase 2 | Dažnai (30–79%) | 1 ligoje |
| PFN1profilin 1 | Dažnai (30–79%) | 1 ligoje |
| PRPHperipherin | Dažnai (30–79%) | 1 ligoje |
| PSAPprosaposin | Dažnai (30–79%) | 3 ligose |
| SLC39A4solute carrier family 39 member 4 | Dažnai (30–79%) | 2 ligose |
| SLC6A17solute carrier family 6 member 17 | Dažnai (30–79%) | 2 ligose |
| SNORD118small nucleolar RNA, C/D box 118 | Dažnai (30–79%) | 1 ligoje |
| SOD1superoxide dismutase 1 | Dažnai (30–79%) | 1 ligoje |
| SPG11SPG11 vesicle trafficking associated, spatacsin | Dažnai (30–79%) | 1 ligoje |
| SPTBN1spectrin beta, non-erythrocytic 1 | Dažnai (30–79%) | 1 ligoje |
| SQSTM1sequestosome 1 | Dažnai (30–79%) | 1 ligoje |
| SRPK3SRSF protein kinase 3 | Dažnai (30–79%) | 1 ligoje |
| TAF15TATA-box binding protein associated factor 15 | Dažnai (30–79%) | 1 ligoje |
| TARDBPTAR DNA binding protein | Dažnai (30–79%) | 2 ligose |
| TBK1TANK binding kinase 1 | Dažnai (30–79%) | 1 ligoje |
| TP53tumor protein p53 | Dažnai (30–79%) | 1 ligoje |
| TREM2triggering receptor expressed on myeloid cells 2 | Dažnai (30–79%) | 1 ligoje |
| UBQLN2ubiquilin 2 | Dažnai (30–79%) | 1 ligoje |
| UNC13Aunc-13 homolog A | Dažnai (30–79%) | 1 ligoje |
| USP48ubiquitin specific peptidase 48 | Dažnai (30–79%) | 1 ligoje |
| USP8ubiquitin specific peptidase 8 | Dažnai (30–79%) | 2 ligose |
| VAPBVAMP associated protein B and C | Dažnai (30–79%) | 1 ligoje |
| VCPvalosin containing protein | Dažnai (30–79%) | 2 ligose |
| ARL6ARF like GTPase 6 | Kartais (5–29%) | 1 ligoje |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Kartais (5–29%) | 1 ligoje |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Kartais (5–29%) | 3 ligose |
| BBIP1BBSome interacting protein 1 | Kartais (5–29%) | 1 ligoje |
| BBS1Bardet-Biedl syndrome 1 | Kartais (5–29%) | 1 ligoje |
| BBS10Bardet-Biedl syndrome 10 | Kartais (5–29%) | 1 ligoje |
| BBS12Bardet-Biedl syndrome 12 | Kartais (5–29%) | 1 ligoje |
| BBS2Bardet-Biedl syndrome 2 | Kartais (5–29%) | 1 ligoje |
| BBS4Bardet-Biedl syndrome 4 | Kartais (5–29%) | 1 ligoje |
| BBS5Bardet-Biedl syndrome 5 | Kartais (5–29%) | 1 ligoje |
| BBS7Bardet-Biedl syndrome 7 | Kartais (5–29%) | 1 ligoje |
| BBS9Bardet-Biedl syndrome 9 | Kartais (5–29%) | 1 ligoje |
| BPTFbromodomain PHD finger transcription factor | Kartais (5–29%) | 1 ligoje |
| BSNDbarttin CLCNK type accessory subunit beta | Kartais (5–29%) | 1 ligoje |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Kartais (5–29%) | 1 ligoje |
| CEP19centrosomal protein 19 | Kartais (5–29%) | 1 ligoje |
| CEP290centrosomal protein 290 | Kartais (5–29%) | 1 ligoje |
| CFAP418cilia and flagella associated protein 418 | Kartais (5–29%) | 1 ligoje |
| CLCNKAchloride voltage-gated channel Ka | Kartais (5–29%) | 1 ligoje |
| CLCNKBchloride voltage-gated channel Kb | Kartais (5–29%) | 1 ligoje |
| CTSFcathepsin F | Kartais (5–29%) | 1 ligoje |
| GABRG2gamma-aminobutyric acid type A receptor subunit gamma2 | Kartais (5–29%) | 1 ligoje |
| GALCgalactosylceramidase | Kartais (5–29%) | 1 ligoje |
| GRIK2glutamate ionotropic receptor kainate type subunit 2 | Kartais (5–29%) | 1 ligoje |
| GRIN2Aglutamate ionotropic receptor NMDA type subunit 2A | Kartais (5–29%) | 2 ligose |
| HTRA1HtrA serine peptidase 1 | Kartais (5–29%) | 1 ligoje |
| IFT172intraflagellar transport 172 | Kartais (5–29%) | 1 ligoje |
| IFT27intraflagellar transport 27 | Kartais (5–29%) | 1 ligoje |
| IFT74intraflagellar transport 74 | Kartais (5–29%) | 1 ligoje |
| LZTFL1leucine zipper transcription factor like 1 | Kartais (5–29%) | 1 ligoje |
| MECP2methyl-CpG binding protein 2 | Kartais (5–29%) | 1 ligoje |
| MIR17HGmiR-17-92a-1 cluster host gene | Kartais (5–29%) | 1 ligoje |
| MKKSMKKS centrosomal shuttling protein | Kartais (5–29%) | 1 ligoje |
| MKS1MKS transition zone complex subunit 1 | Kartais (5–29%) | 1 ligoje |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Kartais (5–29%) | 1 ligoje |
| NAGSN-acetylglutamate synthase | Kartais (5–29%) | 1 ligoje |
| NPHP1nephrocystin 1 | Kartais (5–29%) | 1 ligoje |
| PLA2G6phospholipase A2 group VI | Kartais (5–29%) | 2 ligose |
| POLGDNA polymerase gamma, catalytic subunit | Kartais (5–29%) | 2 ligose |
| PSMD12proteasome 26S subunit, non-ATPase 12 | Kartais (5–29%) | 1 ligoje |
| RFX7regulatory factor X7 | Kartais (5–29%) | 1 ligoje |
| RHOBTB2Rho related BTB domain containing 2 | Kartais (5–29%) | 1 ligoje |
| RNF125ring finger protein 125 | Kartais (5–29%) | 1 ligoje |
| RNF168ring finger protein 168 | Kartais (5–29%) | 1 ligoje |
| RNU2-2RNA, U2 small nuclear 2 | Kartais (5–29%) | 1 ligoje |
| SARDHsarcosine dehydrogenase | Kartais (5–29%) | 1 ligoje |
| SATB2SATB homeobox 2 | Kartais (5–29%) | 1 ligoje |
| SCAPERS-phase cyclin A associated protein in the ER | Kartais (5–29%) | 1 ligoje |
| SCLT1sodium channel and clathrin linker 1 | Kartais (5–29%) | 1 ligoje |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Kartais (5–29%) | 1 ligoje |
| SDCCAG8SHH signaling and ciliogenesis regulator SDCCAG8 | Kartais (5–29%) | 1 ligoje |
| SLC1A3solute carrier family 1 member 3 | Kartais (5–29%) | 1 ligoje |
| SLC2A1solute carrier family 2 member 1 | Kartais (5–29%) | 1 ligoje |
| SPARTspartin | Kartais (5–29%) | 2 ligose |
| SRPX2sushi repeat containing protein X-linked 2 | Kartais (5–29%) | 1 ligoje |
| TNIKTRAF2 and NCK interacting kinase | Kartais (5–29%) | 1 ligoje |
| TRIM32tripartite motif containing 32 | Kartais (5–29%) | 1 ligoje |
| TTC8tetratricopeptide repeat domain 8 | Kartais (5–29%) | 1 ligoje |
| TUBB3tubulin beta 3 class III | Kartais (5–29%) | 1 ligoje |
| TWNKtwinkle mtDNA helicase | Kartais (5–29%) | 1 ligoje |
| VPS13Avacuolar protein sorting 13 homolog A | Kartais (5–29%) | 2 ligose |
| WDPCPWD repeat containing planar cell polarity effector | Kartais (5–29%) | 1 ligoje |
| AKT1AKT serine/threonine kinase 1 | Retai (1–4 %) | 1 ligoje |
| BAP1BRCA1 associated deubiquitinase 1 | Retai (1–4 %) | 1 ligoje |
| NF2NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor | Retai (1–4 %) | 1 ligoje |
| PDGFBplatelet derived growth factor subunit B | Retai (1–4 %) | 1 ligoje |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Retai (1–4 %) | 1 ligoje |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Retai (1–4 %) | 1 ligoje |
| SMARCE1SWI/SNF related BAF chromatin remodeling complex subunit E1 | Retai (1–4 %) | 1 ligoje |
| SMOsmoothened, frizzled class receptor | Retai (1–4 %) | 1 ligoje |
| SUFUSUFU negative regulator of hedgehog signaling | Retai (1–4 %) | 1 ligoje |
| TERTtelomerase reverse transcriptase | Retai (1–4 %) | 1 ligoje |
| TRAF7TNF receptor associated factor 7 | Retai (1–4 %) | 1 ligoje |
| AIPAHR interacting HSP90 co-chaperone | Neužfiksuota | 1 ligoje |
| B4GALNT1beta-1,4-N-acetyl-galactosaminyltransferase 1 | Neužfiksuota | 1 ligoje |
| BCS1LBCS1 ubiquinol-cytochrome c reductase complex chaperone | Neužfiksuota | 1 ligoje |
| C19orf12chromosome 19 open reading frame 12 | Neužfiksuota | 1 ligoje |
| CUL4Bcullin 4B | Neužfiksuota | 1 ligoje |
| DGCR2DiGeorge syndrome critical region gene 2 | Neužfiksuota | 1 ligoje |
| DGCR6DiGeorge syndrome critical region gene 6 | Neužfiksuota | 1 ligoje |
| DGCR8DGCR8 microprocessor complex subunit | Neužfiksuota | 1 ligoje |
| EIF2B1eukaryotic translation initiation factor 2B subunit alpha | Neužfiksuota | 1 ligoje |
| ELP1elongator acetyltransferase complex subunit 1 | Neužfiksuota | 1 ligoje |
| ESS2ess-2 spliceosome associated protein | Neužfiksuota | 1 ligoje |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Neužfiksuota | 1 ligoje |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Neužfiksuota | 1 ligoje |
| MED12mediator complex subunit 12 | Neužfiksuota | 1 ligoje |
| PDE11Aphosphodiesterase 11A | Neužfiksuota | 1 ligoje |
| PGK1phosphoglycerate kinase 1 | Neužfiksuota | 1 ligoje |
| PRKACAprotein kinase cAMP-activated catalytic subunit alpha | Neužfiksuota | 1 ligoje |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Neužfiksuota | 1 ligoje |
| TBX1T-box transcription factor 1 | Neužfiksuota | 1 ligoje |
| TDO2tryptophan 2,3-dioxygenase | Neužfiksuota | 1 ligoje |
| ZFYVE26zinc finger FYVE-type containing 26 | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites